Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

QDEL – QuidelOrtho Corporation

QuidelOrtho Corporation
QDEL
$15.13
Name : QuidelOrtho Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $1,030,077,184.00
EPSttm : -16.69
finviz dynamic chart for QDEL
QuidelOrtho Corporation
$15.13
2.37%
$0.35
QDEL — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

16.32

Margin Of Safety %

Put/Call OI Ratio

0.47

EPS Next Q Diff

-0.34

EPS Last/This Y

18.86

EPS This/Next Y

0.81

Price

14.78

Target Price

33.14

Analyst Recom

2.67

Performance Q

-48.88

Upside

-4,045.2%

Beta

0.95

Ticker: QDEL




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-02QDEL22.610.3321.006777
2026-03-03QDEL21.490.340.576839
2026-03-04QDEL21.180.340.086855
2026-03-05QDEL21.40.340.006857
2026-03-06QDEL20.840.340.956893
2026-03-09QDEL19.850.342.486940
2026-03-10QDEL19.30.360.627120
2026-03-11QDEL18.040.370.227376
2026-03-12QDEL17.910.370.297539
2026-03-13QDEL17.920.370.297539
2026-03-17QDEL19.130.362.347758
2026-03-18QDEL17.090.441.458421
2026-03-19QDEL16.580.431.218452
2026-03-20QDEL15.230.440.258749
2026-03-23QDEL16.540.460.387898
2026-03-24QDEL16.170.450.228045
2026-03-25QDEL16.090.451.458044
2026-03-26QDEL15.590.480.318272
2026-03-27QDEL14.80.471.748344
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-02QDEL22.60-36.41397.92.17
2026-03-03QDEL21.49-36.41357.22.17
2026-03-04QDEL21.18-36.41362.82.17
2026-03-05QDEL21.41-36.41366.82.17
2026-03-06QDEL20.84-36.41361.02.17
2026-03-09QDEL19.85-36.41357.92.17
2026-03-10QDEL19.28-36.41360.92.17
2026-03-11QDEL18.04-36.41355.62.17
2026-03-12QDEL17.93-36.41364.42.17
2026-03-13QDEL17.09-36.41358.72.17
2026-03-17QDEL19.12-36.41376.52.17
2026-03-18QDEL17.11-36.41349.92.17
2026-03-19QDEL16.59-36.41281.32.17
2026-03-20QDEL15.24-36.41272.72.17
2026-03-23QDEL16.54-36.41280.92.17
2026-03-24QDEL16.19-36.41278.72.17
2026-03-25QDEL16.03-36.41277.72.17
2026-03-26QDEL15.58-36.41274.72.17
2026-03-27QDEL14.78-36.41269.72.17
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-02QDEL7.641.6215.11
2026-03-03QDEL7.641.6215.11
2026-03-04QDEL7.641.6215.11
2026-03-05QDEL7.641.6215.11
2026-03-06QDEL7.641.6215.11
2026-03-09QDEL7.641.6015.11
2026-03-10QDEL7.641.6015.11
2026-03-11QDEL7.641.6015.29
2026-03-12QDEL7.641.6015.29
2026-03-13QDEL7.641.6015.29
2026-03-17QDEL7.641.8715.29
2026-03-18QDEL7.641.8715.29
2026-03-19QDEL7.641.8715.29
2026-03-20QDEL7.641.8715.29
2026-03-23QDEL7.641.8715.29
2026-03-24QDEL7.641.8715.29
2026-03-25QDEL7.641.8716.32
2026-03-26QDEL7.641.8716.32
2026-03-27QDEL7.641.8716.32
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.46

Avg. EPS Est. Current Quarter

0.47

Avg. EPS Est. Next Quarter

0.12

Insider Transactions

7.64

Institutional Transactions

1.87

Beta

0.95

Average Sales Estimate Current Quarter

682

Average Sales Estimate Next Quarter

630

Fair Value

Quality Score

36

Growth Score

34

Sentiment Score

10

Actual DrawDown %

91.8

Max Drawdown 5-Year %

-91.3

Target Price

33.14

P/E

Forward P/E

5.09

PEG

0.29

P/S

0.37

P/B

0.52

P/Free Cash Flow

EPS

-16.66

Average EPS Est. Cur. Y​

2.17

EPS Next Y. (Est.)

2.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-41.42

Relative Volume

1.65

Return on Equity vs Sector %

-86.3

Return on Equity vs Industry %

-70.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.29

EBIT Estimation

1269.7
QDEL Healthcare
$14.78
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
5/25
Volume
0/15
Valuation
17/20
TP/AR
0/10
Options
4/10
RSI
28.4
Range 1M
0.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
36 /100
WEAK
Momentum
14/25
Growth
13/30
Estimates
0/20
Inst/Vol
6/15
Options
3/10
EPS Yr
1.2%
EPS NY
35.5%
52W%
0.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +468.1% upside
Quality
4/30
Valuation
22/30
Growth
13/25
Stability
5/10
LT Trend
4/5
Upside
+468.1%
Quality
36
QuidelOrtho Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 6500
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
QDEL

Latest News

Caricamento notizie per QDEL
stock quote shares QDEL – QuidelOrtho Corporation Stock Price stock today
news today QDEL – QuidelOrtho Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch QDEL – QuidelOrtho Corporation yahoo finance google finance
stock history QDEL – QuidelOrtho Corporation invest stock market
stock prices QDEL premarket after hours
ticker QDEL fair value insiders trading

QDEL – Quidel Corporation

QuidelOrtho Corporation
QDEL
$15.13
Name : QuidelOrtho Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $1,030,077,184.00
EPSttm : -16.69
finviz dynamic chart for QDEL
QuidelOrtho Corporation
$15.13
2.37%
$0.35
QDEL — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

16.32

Margin Of Safety %

Put/Call OI Ratio

0.47

EPS Next Q Diff

-0.34

EPS Last/This Y

18.86

EPS This/Next Y

0.81

Price

14.78

Target Price

33.14

Analyst Recom

2.67

Performance Q

-48.88

Upside

-4,045.2%

Beta

0.95

Ticker: QDEL




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-02QDEL22.610.3321.006777
2026-03-03QDEL21.490.340.576839
2026-03-04QDEL21.180.340.086855
2026-03-05QDEL21.40.340.006857
2026-03-06QDEL20.840.340.956893
2026-03-09QDEL19.850.342.486940
2026-03-10QDEL19.30.360.627120
2026-03-11QDEL18.040.370.227376
2026-03-12QDEL17.910.370.297539
2026-03-13QDEL17.920.370.297539
2026-03-17QDEL19.130.362.347758
2026-03-18QDEL17.090.441.458421
2026-03-19QDEL16.580.431.218452
2026-03-20QDEL15.230.440.258749
2026-03-23QDEL16.540.460.387898
2026-03-24QDEL16.170.450.228045
2026-03-25QDEL16.090.451.458044
2026-03-26QDEL15.590.480.318272
2026-03-27QDEL14.80.471.748344
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-02QDEL22.60-36.41397.92.17
2026-03-03QDEL21.49-36.41357.22.17
2026-03-04QDEL21.18-36.41362.82.17
2026-03-05QDEL21.41-36.41366.82.17
2026-03-06QDEL20.84-36.41361.02.17
2026-03-09QDEL19.85-36.41357.92.17
2026-03-10QDEL19.28-36.41360.92.17
2026-03-11QDEL18.04-36.41355.62.17
2026-03-12QDEL17.93-36.41364.42.17
2026-03-13QDEL17.09-36.41358.72.17
2026-03-17QDEL19.12-36.41376.52.17
2026-03-18QDEL17.11-36.41349.92.17
2026-03-19QDEL16.59-36.41281.32.17
2026-03-20QDEL15.24-36.41272.72.17
2026-03-23QDEL16.54-36.41280.92.17
2026-03-24QDEL16.19-36.41278.72.17
2026-03-25QDEL16.03-36.41277.72.17
2026-03-26QDEL15.58-36.41274.72.17
2026-03-27QDEL14.78-36.41269.72.17
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-02QDEL7.641.6215.11
2026-03-03QDEL7.641.6215.11
2026-03-04QDEL7.641.6215.11
2026-03-05QDEL7.641.6215.11
2026-03-06QDEL7.641.6215.11
2026-03-09QDEL7.641.6015.11
2026-03-10QDEL7.641.6015.11
2026-03-11QDEL7.641.6015.29
2026-03-12QDEL7.641.6015.29
2026-03-13QDEL7.641.6015.29
2026-03-17QDEL7.641.8715.29
2026-03-18QDEL7.641.8715.29
2026-03-19QDEL7.641.8715.29
2026-03-20QDEL7.641.8715.29
2026-03-23QDEL7.641.8715.29
2026-03-24QDEL7.641.8715.29
2026-03-25QDEL7.641.8716.32
2026-03-26QDEL7.641.8716.32
2026-03-27QDEL7.641.8716.32
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.46

Avg. EPS Est. Current Quarter

0.47

Avg. EPS Est. Next Quarter

0.12

Insider Transactions

7.64

Institutional Transactions

1.87

Beta

0.95

Average Sales Estimate Current Quarter

682

Average Sales Estimate Next Quarter

630

Fair Value

Quality Score

36

Growth Score

34

Sentiment Score

10

Actual DrawDown %

91.8

Max Drawdown 5-Year %

-91.3

Target Price

33.14

P/E

Forward P/E

5.09

PEG

0.29

P/S

0.37

P/B

0.52

P/Free Cash Flow

EPS

-16.66

Average EPS Est. Cur. Y​

2.17

EPS Next Y. (Est.)

2.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-41.42

Relative Volume

1.65

Return on Equity vs Sector %

-86.3

Return on Equity vs Industry %

-70.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.29

EBIT Estimation

1269.7
QDEL Healthcare
$14.78
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
5/25
Volume
0/15
Valuation
17/20
TP/AR
0/10
Options
4/10
RSI
28.4
Range 1M
0.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
36 /100
WEAK
Momentum
14/25
Growth
13/30
Estimates
0/20
Inst/Vol
6/15
Options
3/10
EPS Yr
1.2%
EPS NY
35.5%
52W%
0.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +468.1% upside
Quality
4/30
Valuation
22/30
Growth
13/25
Stability
5/10
LT Trend
4/5
Upside
+468.1%
Quality
36
QuidelOrtho Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 6500
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
QDEL

Latest News

Caricamento notizie per QDEL
stock quote shares QDEL – Quidel Corporation Stock Price stock today
news today QDEL – Quidel Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch QDEL – Quidel Corporation yahoo finance google finance
stock history QDEL – Quidel Corporation invest stock market
stock prices QDEL premarket after hours
ticker QDEL fair value insiders trading